Comparing the Effects of Positional Release Technique Versus Myofascial Release Technique of Gluteus Medius

March 24, 2021 updated by: Priyanka Ratan Kumar, Dow University of Health Sciences

Comparing the Effects of Positional Release Technique Versus Myofascial Release Technique of Gluteus Medius in the Management of Patellofemoral Pain Syndrome - A Randomized Control Trial

Patellofemoral pain syndrome is a condition of misleading diagnosis. It mostly affects individuals with ages between 18-40 years. It is believed that much work has been done on the joint itself in treating the Quadriceps muscles and triggers related to it but now literature is focusing on the segmental involvement, where weakness of the hip abductors and lateral rotators play a major role. Therefore, interventions used for treating this syndrome should include on focusing the hip muscles for trigger point therapy as well as strengthening them in increasing the stability of the hip and pelvis to reduce excessive valgus forces on the knee.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Literature regarding Gluteus Medius trigger point is quite scarce especially in alleviating the pain related to Patellofemoral Pain Syndrome. The management of Patellofemoral Pain Syndrome includes a segmental treatment, giving special focus to the lateral rotators and abductors of the hip especially Gluteus Medius muscle, rather than treating the Patellofemoral Joint itself. It will help in improving the pain of the subjects suffering from this syndrome effectively, and within a shorter duration of time. It will also provide the practicing physiotherapist with an insight for treating such patients with better outcomes. Myofascial Trigger Points of the Gluteus Medius are important contributing factors in the management of Patellofemoral Pain Syndrome which is identified in a single study as per author's knowledge. But the treatment used to release the trigger point of Gluteus Medius in managing this syndrome has not yet been explored. So, this study will compare two well-known treatments in comprehending which one of the two techniques have better effects on the population to be studied. Written consent will be taken from all the study participants. Simple randomization technique will be used through "Randomization Main" software and randomization sheet will be generated. 60 participants with patellofemoral pain syndrome having Gluteus Medius trigger point will be randomly allocated in two equal group.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan, 74200
        • Sindh Institute of Physical Medicine and Rehabilitation, Karachi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Anterior knee pain >1month and <3 month
  • Pain in activities like ascending & descending stairs, running or sports activity & prolonged sitting
  • Presence of Gluteus Medius trigger point in the affected limb
  • Age group 18-40 years
  • Both genders

Exclusion Criteria:

  • Dislocation of Patella
  • Damaged cartilage and ligament of Knee Joint
  • Soft tissue injury related to Knee
  • Any knee or hip surgery
  • Lumbar spine dysfunction
  • Sacroiliac joint dysfunction
  • Pelvic malalignment
  • Flat foot
  • Chondromalacia patellae
  • Young onset Osteoarthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental

Following physiotherapy will be given to the participants in this group for 6 weeks, 2 times a week:

1. Positional Release Technique 2. Ultrasound 3. Cold Packs 4. Hip Strengthening Exercises 5. Knee Strengthening exercises

Treatment will be given in 3 sessions per week for 6 weeks with home exercise program and participants will be provided with exercises sheets to remember the exercises.

The selected outcome measure will be taken on baseline (initial visit) and 6th week (post intervention)

Active Comparator: Comparator

Following physiotherapy will be given to the participants in this group for 6 weeks, 2 times a week:

1. Myofascial Release Technique 2. Ultrasound 3. Cold Packs 4. Hip Strengthening Exercises 5. Knee Strengthening exercises

Treatment will be given in 3 sessions per week for 6 weeks with home exercise program and participants will be provided with exercises sheets to remember the exercises.

The selected outcome measure will be taken on baseline (initial visit) and 6th week (post intervention)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anterior Knee pain Scale
Time Frame: Baseline and end of intervention (6th week)
It is 13-item questionnaire with different categories relating various levels of individual's current knee function. Score ranges from 1 representing severe disability to 100 representing no disability.
Baseline and end of intervention (6th week)
Visual Analog Scale
Time Frame: Baseline and end of intervention (6th week)
A subjective psychometric response scale used to measure discrete behavioral or physiological phenomena based on linear numerical gradient in measuring the intensity of pain.
Baseline and end of intervention (6th week)
Pain Pressure Threshold
Time Frame: Baseline and end of intervention (6th week)
It is the amount of direct pressure required in eliciting a response in pain on a selected area obtained by an Algometer in kilograms (kg.)
Baseline and end of intervention (6th week)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle strength
Time Frame: Baseline and end of intervention (6th week)
In kilograms (kg.) obtained by Hand Held Dynamometer
Baseline and end of intervention (6th week)
World Health Organization Quality of Life Questionnaire- Brief
Time Frame: Baseline and end of intervention (6th week)
An integrated instrument used to evaluate health related quality of life. It is a 26-item version of the WHOQOL-100 assessment.
Baseline and end of intervention (6th week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Priyanka Kumar, MSAPT, Dow University of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 7, 2020

Primary Completion (Actual)

March 15, 2021

Study Completion (Actual)

March 24, 2021

Study Registration Dates

First Submitted

December 3, 2020

First Submitted That Met QC Criteria

December 9, 2020

First Posted (Actual)

December 14, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2021

Last Update Submitted That Met QC Criteria

March 24, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Results will be explored through publications.

IPD Sharing Time Frame

Results will be explored through publications.

IPD Sharing Access Criteria

Results will be explored through publications.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on Physiotherapy

3
Subscribe